Creative Biolabs-Immuno-oncology

Anti-MERTK (clone M9Q) SynExpress trc-mSc-cJ-H Modified CD8+ T cells (CAT#: ITS-1224-CR1110)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target MERTK (clone M9Q). We employs the AAV (trc-mScarlet-c-Jun-HindIII) vector components and the SynExpress system of the Single base pair Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
MERTK
Clone
M9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mScarlet
Promoter
trc
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Base Editing
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.9
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.